Skip to main content
TipRanks
Go Ultimate75% OFF

OSE Immunotherapeutics SA (0RAD) Revenue

2 Followers

OSE Immunotherapeutics SA Revenue

OSE Immunotherapeutics SA had a revenue of 1.30M in the quarter ending Dec 31, 2025, with -2.04%. This bring the company's revenue in the last twelve months to 2.62M, Increased 21.59%. In the fiscal year ending Dec 31, 2025, OSE Immunotherapeutics SA had annual revenue of 2.62M with -96.25% growth.

Revenue (ttm)
2.62M
Revenue Growth
-96.25%
P/S Ratio
13.11
Revenue/Employee
EUR 40,922
Employees
64
Market Cap
EUR 34.33M

Revenue Chart

OSE Immunotherapeutics SA Revenue - Annual

020M40M60M80M6.68M24.46M25.95M10.42M26.31M18.30M2.23M69.88M2.62M201720182019202020212022202320242025
Revenue History
Download to Excel
GB:0RAD revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 20252.62M-67.26M-96.25%
Dec 31, 202469.88M67.65M3037.72%
Dec 31, 20232.23M-16.07M-87.83%
Dec 31, 202218.30M-8.00M-30.43%
Dec 31, 202126.31M15.89M152.51%
Dec 31, 202010.42M-15.53M-59.86%
Dec 31, 201925.95M1.50M6.12%
Dec 31, 201824.46M17.77M266.00%
Dec 31, 20176.68M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
GB:0RAD2.62M
FR:IPH1.04M
FR:ABVX-2.02M
FR:TNG313.00K
FR:ALCLS56.58M
FR:MAAT3.18M